Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 25 | IDXX IDEXX Laboratories | Common Stock | Payment of exercise | Dispose F | No | No | 444.53 | 272 | 120.91 k | 7,103.235 |
14 Feb 25 | IDXX IDEXX Laboratories | Common Stock | Option exercise | Acquire M | No | No | 0 | 301 | 0.00 | 7,375.235 |
14 Feb 25 | IDXX IDEXX Laboratories | Common Stock | Option exercise | Acquire M | No | No | 0 | 220 | 0.00 | 7,074.235 |
14 Feb 25 | IDXX IDEXX Laboratories | Common Stock | Option exercise | Acquire M | No | No | 0 | 204 | 0.00 | 6,854.235 |
14 Feb 25 | IDXX IDEXX Laboratories | Common Stock | Option exercise | Acquire M | No | No | 0 | 160 | 0.00 | 6,650.235 |
14 Feb 25 | IDXX IDEXX Laboratories | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 301 | 0.00 | 903 |
14 Feb 25 | IDXX IDEXX Laboratories | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 220 | 0.00 | 440 |
14 Feb 25 | IDXX IDEXX Laboratories | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 204 | 0.00 | 204 |
14 Feb 25 | IDXX IDEXX Laboratories | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 160 | 0.00 | 0 |
13 Feb 25 | IDXX IDEXX Laboratories | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,468 | 0.00 | 1,468 |